Name | Number of supported studies  | Average coverage | |
|---|---|---|---|
| type II pneumocyte | 6 studies | 25% ± 11% | |
| retinal ganglion cell | 4 studies | 69% ± 28% | |
| GABAergic neuron | 4 studies | 44% ± 9% | |
| neuron | 3 studies | 20% ± 4% | |
| glutamatergic neuron | 3 studies | 52% ± 15% | |
| oligodendrocyte precursor cell | 3 studies | 22% ± 5% | |
| astrocyte | 3 studies | 32% ± 20% |
Name | Number of supported studies | Average coverage | |
|---|---|---|---|
| brain | 3 studies | 37% ± 6% |
Tissue | GTEx Coverage | GTEx Average TPM | GTEx Number of samples | TCGA Coverage | TCGA Average TPM | TCGA Number of samples |
|---|---|---|---|---|---|---|
| thymus | 100% | 2646.82 | 651 / 653 | 98% | 56.49 | 591 / 605 |
| brain | 98% | 4102.95 | 2580 / 2642 | 99% | 69.04 | 700 / 705 |
| prostate | 96% | 2289.72 | 236 / 245 | 99% | 66.06 | 497 / 502 |
| kidney | 94% | 1277.78 | 84 / 89 | 98% | 65.90 | 879 / 901 |
| adrenal gland | 100% | 4775.60 | 258 / 258 | 90% | 76.88 | 207 / 230 |
| lung | 97% | 2666.97 | 563 / 578 | 84% | 44.25 | 967 / 1155 |
| ovary | 100% | 2486.74 | 180 / 180 | 70% | 17.11 | 299 / 430 |
| intestine | 92% | 1142.50 | 887 / 966 | 77% | 33.63 | 407 / 527 |
| pancreas | 62% | 493.42 | 202 / 328 | 92% | 37.05 | 163 / 178 |
| breast | 90% | 1362.77 | 411 / 459 | 63% | 13.28 | 705 / 1118 |
| bladder | 90% | 1012.95 | 19 / 21 | 52% | 20.40 | 263 / 504 |
| uterus | 98% | 3223.84 | 167 / 170 | 41% | 14.57 | 186 / 459 |
| liver | 57% | 507.95 | 128 / 226 | 78% | 23.87 | 318 / 406 |
| skin | 37% | 532.46 | 678 / 1809 | 73% | 45.76 | 344 / 472 |
| stomach | 30% | 305.96 | 109 / 359 | 71% | 28.33 | 203 / 286 |
| blood vessel | 100% | 4804.56 | 1333 / 1335 | 0% | 0 | 0 / 0 |
| esophagus | 60% | 868.03 | 866 / 1445 | 40% | 9.47 | 73 / 183 |
| muscle | 99% | 3984.77 | 795 / 803 | 0% | 0 | 0 / 0 |
| adipose | 99% | 2047.54 | 1189 / 1204 | 0% | 0 | 0 / 0 |
| spleen | 98% | 1990.46 | 236 / 241 | 0% | 0 | 0 / 0 |
| heart | 85% | 1526.20 | 733 / 861 | 0% | 0 | 0 / 0 |
| eye | 0% | 0 | 0 / 0 | 59% | 11.60 | 47 / 80 |
| lymph node | 0% | 0 | 0 / 0 | 31% | 3.90 | 9 / 29 |
| tonsil | 0% | 0 | 0 / 0 | 13% | 1.67 | 6 / 45 |
| peripheral blood | 9% | 131.87 | 85 / 929 | 0% | 0 | 0 / 0 |
| abdomen | 0% | 0 | 0 / 0 | 0% | 0 | 0 / 0 |
| bone marrow | 0% | 0 | 0 / 0 | 0% | 0 | 0 / 0 |
| diaphragm | 0% | 0 | 0 / 0 | 0% | 0 | 0 / 0 |
| gingiva | 0% | 0 | 0 / 0 | 0% | 0 | 0 / 0 |
| nasal cavity | 0% | 0 | 0 / 0 | 0% | 0 | 0 / 0 |
| nasopharynx | 0% | 0 | 0 / 0 | 0% | 0 | 0 / 0 |
| nose | 0% | 0 | 0 / 0 | 0% | 0 | 0 / 0 |
| placenta | 0% | 0 | 0 / 0 | 0% | 0 | 0 / 0 |
| spinal column | 0% | 0 | 0 / 0 | 0% | 0 | 0 / 0 |
| ureter | 0% | 0 | 0 / 0 | 0% | 0 | 0 / 1 |
| GO_1990764 | Biological process | myofibroblast contraction |
| GO_0007160 | Biological process | cell-matrix adhesion |
| GO_0043202 | Cellular component | lysosomal lumen |
| GO_0005764 | Cellular component | lysosome |
| GO_0005576 | Cellular component | extracellular region |
| GO_1905573 | Molecular function | ganglioside GM1 binding |
| GO_0005509 | Molecular function | calcium ion binding |
| GO_0042802 | Molecular function | identical protein binding |
| GO_0005515 | Molecular function | protein binding |
| GO_0005543 | Molecular function | phospholipid binding |
| Gene name | EPDR1 |
| Protein name | Mammalian ependymin-related protein 1 Mammalian ependymin-related protein 1 (MERP-1) (Upregulated in colorectal cancer gene 1 protein) |
| Synonyms | MERP1 hCG_16680 tcag7.449 UCC1 |
| Description | FUNCTION: Binds anionic lipids and gangliosides at acidic pH. . FUNCTION: Binds anionic lipids and gangliosides at acidic pH. . |
| Accessions | A4D1W8 ENST00000199448.9 [Q9UM22-1] ENST00000423717.1 [Q9UM22-2] ENST00000425345.1 [Q9UM22-3] Q9UM22 |
